Metabiota is a pioneer in comprehensive risk analytics that improve the world's resilience to epidemics. Built on a strong foundation of epidemiology and international field science, including a worldwide network of on-the ground experts, the company delivers actionable, data-driven insights that help countries, governments, and corporations manage and mitigate infectious diseases. With a strategic global presence and sustained partnerships, Metabiota's agile approach is helping the world track and transfer the risk associated with epidemic threats. Metabiota has the most comprehensive infectious disease database, covering a century of human outbreak events. Data from hundreds of sources has been curated and organized to enable visualization of the frequency, severity and duration of outbreaks. Risk from emerging disease threats around the world can be managed with near real-time surveillance data. Events are tracked as they unfold and our clients' exposure is analyzed to quantify the resulting impact, and to visualize the spread and containment of events at the global, country and sub-national levels.
Select investors Capricorn Healthcare, Data Collective, GV, Pilot Growth Equity, SciFi VC, Industry Ventures, SharesPost Investment Management
Last update: May 30, 2018
Disclaimer: We can not guarantee that the information on this page is 100% correct. more